/
/
/

Aarti Pharmalabs Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
₹536 Cr₹583 Cr₹432 Cr₹418 Cr₹386 Cr₹564 Cr₹538 Cr₹458 Cr₹555 Cr₹506 Cr₹449 Cr₹440 Cr₹458 Cr₹485 Cr₹472 Cr₹531 Cr₹457 Cr₹460 Cr
₹45 L₹8 Cr-₹37 L₹5 L₹77 L₹86 L₹5 Cr₹4 Cr₹2 Cr₹2 Cr₹1 Cr₹99 L₹48 L₹74 L₹29 L₹1 Cr₹2 L₹3 Cr
₹536 Cr₹591 Cr₹432 Cr₹418 Cr₹387 Cr₹565 Cr₹543 Cr₹463 Cr₹558 Cr₹508 Cr₹450 Cr₹441 Cr₹459 Cr₹486 Cr₹472 Cr₹532 Cr₹457 Cr₹463 Cr
₹430 Cr₹498 Cr₹359 Cr₹368 Cr₹318 Cr₹443 Cr₹432 Cr₹385 Cr₹479 Cr₹407 Cr₹372 Cr₹370 Cr₹391 Cr₹421 Cr₹402 Cr₹458 Cr₹385 Cr₹399 Cr
₹137 Cr₹121 Cr₹102 Cr₹75 Cr₹92 Cr₹144 Cr₹134 Cr₹98 Cr₹99 Cr₹120 Cr₹97 Cr₹89 Cr₹85 Cr₹81 Cr₹87 Cr₹91 Cr₹86 Cr₹78 Cr
₹13 Cr₹17 Cr₹13 Cr₹11 Cr₹7 Cr₹7 Cr₹10 Cr₹6 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹6 Cr₹5 Cr₹6 Cr₹4 Cr₹5 Cr
₹94 Cr₹76 Cr₹58 Cr₹39 Cr₹63 Cr₹115 Cr₹101 Cr₹72 Cr₹74 Cr₹96 Cr₹74 Cr₹67 Cr₹64 Cr₹59 Cr₹65 Cr₹69 Cr₹68 Cr₹59 Cr
₹69 Cr₹56 Cr₹43 Cr₹29 Cr₹48 Cr₹88 Cr₹74 Cr₹55 Cr₹55 Cr₹65 Cr₹53 Cr₹52 Cr₹47 Cr₹43 Cr₹48 Cr₹51 Cr₹52 Cr₹49 Cr

Share Price Live Stats

Open (₹)872.00
Volume (₹)3.86 L
High (₹)879.75
Upper Circuit1,041.70
Low (₹)854.10
Lower Circuit694.50
Prev Close868.10
52W High (₹)946.10
Price864.45
52W Low (₹)585.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)7852.42 Cr
Div. Yield (%)0.40
PE Ratio36.84
Debt to Equity0.32
Price to Book2.52
Book Value234.02
EPS (TTM)23.51
Face Value5.00
ROE (%)8.50

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
AARTIPHARMNSE
LTP
1W Low
1W High
Market cap (₹)
1900-20 (-1.04%)
1896.80
1984.80
4,56,833Cr
9150-89 (-0.96%)
9087
9467
2,45,426Cr
4827-223 (-4.42%)
4823
5066
1,87,320Cr
1126.9-64.1 (-5.38%)
1125.10
1187
1,13,217Cr
1379.9-43.6 (-3.06%)
1376
1426.10
1,12,212Cr
1845.6-92.9 (-4.79%)
1811.70
1949
1,01,155Cr
2110.3-61.2 (-2.82%)
2107.20
2192
97,626Cr
2331-51.9 (-2.18%)
2327.30
2419.20
96,859Cr
1157.1-20.9 (-1.77%)
1154.40
1179.90
96,406Cr
1650.1+4.8 (0.29%)
1622.60
1717
93,614Cr
864.45+23.75 (2.83%)
829
886.95
7,852Cr

Key Highlights of Aarti Pharmalabs Ltd’s P&L

In 2026-03-31, Aarti Pharmalabs Ltd reported total revenue of ₹1829.19Cr, compared with ₹2125.19Cr in 2025-03-31, reflecting Aarti Pharmalabs Ltd turnover.

Depreciation was ₹104.33Cr and finance costs were ₹46.9Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹232.92Cr in 2026-03-31 as compared to ₹360.69Cr in 2025-03-31.

Net Profit (PAT) was ₹174.71Cr in 2026-03-31 compared with ₹272.4Cr in 2025-03-31.

Earnings per share (EPS) were ₹19.27 in 2026-03-31, compared with ₹30.06 in 2025-03-31.